The anti-counterfeit packaging market is forecasted to reach US$206.57 billion by 2021, just shy of doubling its 2016 figure of $107.26 bn. This growth is supported by the expanding pharma and food and beverage industries, with Asia Pacific set to take the largest market share. China is earmarked to lead the way in 2021 with its drive in manufacturing activities fueling that lead.
The anti-tampering market is littered with challenges to address: meeting EU FMD requirements, satisfying country specific requirements, preserving patient usability and not to mention outwitting resourceful counterfeiters. In this ebook we look at the road to meeting the 2019 FMD deadline, finding the most suitable anti tamper evidence feature as well as patient compliance and future trends in the industry.
Edelmann GmbH/ Convenor of ISO TC 122 WG 15 “Tamper Verification Features on medicinal product packaging
Ahead of the Pharmaceutical Packaging and Labelling Summit 2018, we have put together this article on the costs and challenges of compliance in the complex regulatory landscape of the FMD, including the financial implications, maintaining cost- efficiency and the future of the regulatory landscape.
Key opportunities for smart packaging within pharmaceuticals include the promotion of therapy adherence, more organised and efficient data collection and the growth of personalised medicines. However, there are several obstacles which may hinder the widespread implementation of smart technologies, the most prevalent of which is bringing these projects to scale in an affordable manner.
This article discusses the realities of smart packaging implementation, the tangible benefits it can bring to both pharma and patients, and the direction in which the industry is likely to develop over the coming years.
We have put together the very best content pieces from 2018 into one handy industry guide. This guide includes: Serialisation Track and Trace Map, Tackling Tampering in Pharma Packaging, Smart Packaging Solutions and much more!
Having a dedicated Artwork Management System for managing packaging and labelling for your organization is essential. However, many companies attempt to build a system internally, using a variety of tools that interface poorly with each other, adding challenges over a paper based system. Perigord’s Global Quality Director, Suzanne Ivory lays out the pros and cons of building or buying an AMS and offers recommendations to companies considering adopting one, including validation issues, platform security and more.
companies need to define, specify, test and choose the tamper verification
feature for their existing and future packaging portfolio. This article will explore the weak points in anti tampering packaging in relation to pharmaceutical products and how these areas can be addressed.